Presented
by

Presented by Oxford Global

Monthly Newsletter Sign-up

Next Up

Organ Modelling UK: In-Person

21- 22 April 2022 |

BST (UTC+1)

21- 22 April 2022

BST (UTC+1)

+ Digital Day: 25 April 2022 | Online

Bringing together expert leaders to discover the latest tools and strategies for advanced organ model development.

> Visit Event Website

13 Jan 2022
Thu, 13 January 2022

Unlocking Innovation in Drug Discovery with IPU-powered AI

Presented by Alex Titterton, Field Applications Engineer, Graphcore

> More Information

Jun 2022
June 2022

Discovery Europe: In-Person

Join and network with over 500 industry leaders at the renowned Drug Discovery Summit in Berlin, where we will address the latest advancements in target identification, validation and HIT optimisation.

> Visit Event Website

15 Sep 2022
Thu, 15 September 2022

Neuroscience Discovery Symposium

> Visit Event Website

> See All Upcoming Oxford Global Discovery Events
> See All Webinars & Recordings

Highlights

Panel Discussion: Novel Drug Targets
Panel Discussion
Panel Discussion: Novel Drug Targets
Join Steve Rees, Pieter Fokko Van Loo, and Vivek Vishnudas for a discussion on novel drug targets.
08 November 2021
Target Based Discovery
C-Level Q&As
Q&A With Malcolm Weir, Executive Vice Chairman of Sosei Heptares
01 Nov 2021
Discovery Series
Commentary
Covalent Inhibitors Discovery: Advancements and Developments
By Oliver Picken |
12 Oct 2021
Target Based Discovery

Insights

Malcolm Weir C-Level Q&A
C-Level Q&As
Q&A With Malcolm Weir, Executive Vice Chairman of Sosei Heptares
Join us as we sit down with Malcom Weir (Executive Vice Chairman, Sosei Heptares) to discuss the Drug Discovery landscape and recent therapeutic innovations.
01 November 2021
Covalent Inhibitors
Commentary
Covalent Inhibitors Discovery: Advancements and Developments
Covalent inhibitors have progressed significantly since they were discovered in the 18th century and are now experiencing a resurgence.
12 October 2021
Off-The-Shelf-Immunotherapy
Insight Article
Improving the Translation of Disease Biology Through Phenomics
Paul Andrews, Director of Operations and Dundee Lab Head, National Phenotypic Screening Centre (NPSC), University of Dundee
11 June 2019
bacteria-3658992_1920
Insight Article
Tackling the Antimicrobial Resistance Crisis
Sheila Connelly, Vice President, Research, Synthetic Biologies, Inc.
07 June 2018
> See All

[sponsor section - bespoke content]

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.